Matthew B. Klein, CHIEF EXECUTIVE OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 15,584 shares at $50.10 ($781K) on 2025-02-19, disclosed to the SEC on 2025-02-21.
Scheduled sale ($781k) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.10 | 3,897 | $195K | 25.0% |
| 2 | $50.10 | 3,897 | $195K | 25.0% |
| 3 | $50.12 | 3,895 | $195K | 25.0% |
| 4 | $50.12 | 3,895 | $195K | 25.0% |
| Total | $50.11 avg | 15,584 | $781K | 100% |
| Filing → |
| PTCT | SELL | 2026-05-15 | $917K | — | Filing → |
| PTCT | SELL | 2026-04-23 | $202K | — | Filing → |
| PTCT | SELL | 2026-03-13 | $171K | — | Filing → |